Published in J Cell Sci on March 01, 1997
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol (2011) 4.24
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol (2001) 3.32
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol (2000) 2.87
Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases. Mol Biol Cell (2001) 2.53
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest (2008) 2.29
Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J (2001) 2.23
CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J (2002) 2.05
Matrix remodeling during endochondral ossification. Trends Cell Biol (2004) 1.97
Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol (2011) 1.77
Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol (2001) 1.71
Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest (2000) 1.70
Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest (1999) 1.67
The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood (2014) 1.57
Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke. Am J Pathol (2013) 1.54
Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol (2006) 1.50
Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem (2004) 1.24
Visualization of polarized membrane type 1 matrix metalloproteinase activity in live cells by fluorescence resonance energy transfer imaging. J Biol Chem (2008) 1.18
Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol (2007) 1.15
Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth. Am J Pathol (2007) 1.09
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol (2002) 1.08
Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol Biol Cell (2005) 1.07
The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface. J Biol Chem (2008) 0.99
Anterior segment dysgenesis and early-onset glaucoma in nee mice with mutation of Sh3pxd2b. Invest Ophthalmol Vis Sci (2011) 0.98
An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer. PLoS One (2012) 0.93
Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44. Clin Exp Metastasis (2004) 0.89
Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation. Clin Exp Metastasis (2009) 0.88
Podosomes in space: macrophage migration and matrix degradation in 2D and 3D settings. Cell Adh Migr (2014) 0.88
Analysis of the signaling pathways regulating Src-dependent remodeling of the actin cytoskeleton. Eur J Cell Biol (2010) 0.87
MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion. J Biol Chem (2013) 0.87
Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis. Indian J Pharmacol (2012) 0.87
Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts. Histochem Cell Biol (2016) 0.86
Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts. Biomed Res Int (2013) 0.85
Formation of atypical podosomes in extravillous trophoblasts regulates extracellular matrix degradation. Eur J Cell Biol (2012) 0.83
Focal adhesion kinases in adhesion structures and disease. J Signal Transduct (2012) 0.81
Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade. Arthritis Rheumatol (2016) 0.81
Bone marrow stromal cell lines having high potential for osteoclast-supporting activity express PPARgamma1 and show high potential for differentiation into adipocytes. J Bone Miner Metab (2008) 0.80
Alveolarization genes modulated by fetal tracheal occlusion in the rabbit model for congenital diaphragmatic hernia: a randomized study. PLoS One (2013) 0.80
Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis. Clin Exp Metastasis (2008) 0.80
Palladin regulation of the actin structures needed for cancer invasion. Cell Adh Migr (2013) 0.79
Podosomes and Invadopodia: Related structures with Common Protein Components that May Promote Breast Cancer Cellular Invasion. Breast Cancer (Auckl) (2008) 0.77
Expression of MT1-MMP during deciduous tooth resorption in odontoclasts. J Bone Miner Metab (2006) 0.76
Metabolic activation stimulates acid secretion and expression of matrix degrading proteases in human osteoblasts. Ann Rheum Dis (2004) 0.75
Osteocytes and Skeletal Pathophysiology. Curr Mol Biol Rep (2015) 0.75
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol (2000) 2.87
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84
The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem (1998) 2.48
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res (2000) 2.32
Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med (1991) 2.31
A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab (2012) 2.16
Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol (2007) 1.83
Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med (1997) 1.68
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res (2003) 1.68
Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone (2000) 1.60
Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions. Leuk Res (2008) 1.58
Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun (1995) 1.56
Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood (1989) 1.55
Isotope dilution-liquid chromatography/electrospray ionization-tandem mass spectrometry for the determination of serum thyroxine as a potential reference method. Rapid Commun Mass Spectrom (1998) 1.55
Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett (2000) 1.50
Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem (1994) 1.49
Cloning and expression of the Pasteurella multocida toxin gene, toxA, in Escherichia coli. Infect Immun (1989) 1.48
In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun (1984) 1.46
The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res (2002) 1.41
3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler (2008) 1.39
Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci (1995) 1.36
Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta (2000) 1.33
Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol (1992) 1.26
Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization. J Biol Chem (1991) 1.19
Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res (1992) 1.17
Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP beta, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J Biol Chem (2000) 1.17
Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. J Bone Miner Res (1996) 1.15
Large scale isolation of osteoclast-specific genes by an improved method involving the preparation of a subtracted cDNA library. Genes Cells (1998) 1.14
Electron microscopy of oral cells in vitro. II. Subsurface and intracytoplasmic confronting cisternae in strain KB cells. J Cell Biol (1968) 1.14
Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun (1998) 1.13
Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res (1995) 1.11
The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. Osteoarthritis Cartilage (2008) 1.11
Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun (1992) 1.10
Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. J Immunol (2000) 1.10
Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor. J Biol Chem (1986) 1.09
Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology (1992) 1.09
Blocking enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serotype 2. J Clin Microbiol (1991) 1.08
Immunoreactive collagenase and bone resorption. Biochim Biophys Acta (1981) 1.04
Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem (1997) 1.03
The circumfusion system for multipurposeculture chambers. II. The protracted maintenance of differentiation of fetal and newborn mouse liver in vitro. J Cell Biol (1968) 1.01
Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone-induced bone resorption. Biochem J (1986) 1.00
Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem J (1980) 0.99
The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors. J Bone Miner Res (1998) 0.98
Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues. Biochem Biophys Res Commun (1990) 0.97
A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem Biophys Res Commun (1985) 0.97
Breast cancer cells express cathepsins B and L but not cathepsins K or H. Cancer Biochem Biophys (1999) 0.97
Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol (Noisy-le-grand) (2000) 0.97
Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res (1999) 0.96
Selective inhibition of type I collagen synthesis in osteoblastic cells by epidermal growth factor. Endocrinology (1984) 0.96
Atrophic rhinitis in pigs: proposal for a revised definition. Vet Rec (1988) 0.96
[Osteoclasts in bone metabolism]. Kaibogaku Zasshi (1991) 0.96
Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chondromodulin-I and -II. FEBS Lett (1997) 0.96
Effects of epidermal growth factor on osteoblastic cells in vitro. Calcif Tissue Int (1983) 0.96
1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells. Endocrinology (1988) 0.96
Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem (1994) 0.95
Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun (1996) 0.95
Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res (1998) 0.95
Mechanism of stimulation of osteoclastic bone resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse osteoclasts. J Biol Chem (2000) 0.94
Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem (2000) 0.93
Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. Biochem Biophys Res Commun (1998) 0.93
Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis. Infect Immun (1991) 0.93
Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay. J Bone Miner Res (1996) 0.93
Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway. J Biol Chem (2001) 0.93
Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors. J Comb Chem (2000) 0.92
Parathyroid hormone-activated volume-sensitive calcium influx pathways in mechanically loaded osteocytes. J Biol Chem (2000) 0.92
Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106. Bone (1996) 0.91
Effect of epidermal growth factor on collagen formation in liver-derived epithelial clone cells. Endocrinology (1982) 0.90
Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells. J Cell Physiol (1986) 0.90
Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts. Stem Cells (1998) 0.90
Prostaglandin E1 and F2 alpha stimulate differentiation and proliferation, respectively, of clonal osteoblastic MC3T3-E1 cells by different second messengers in vitro. Endocrinology (1987) 0.90
Electron microscopy of oral cells in vitro. I. Annulate lamellae observed in strain KB cells. J Cell Biol (1967) 0.90
Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP. Biochim Biophys Acta (1988) 0.90
Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology (1986) 0.89
No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women. Bone (2000) 0.89
Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol Pharm Bull (1996) 0.89
PEGA supports for combinatorial peptide synthesis and solid-phase enzymatic library assays. J Pept Sci (1998) 0.89
Induction of pneumonia in rabbits by use of a purified protein toxin from Pasteurella multocida. Am J Vet Res (1991) 0.88
Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures. J Bone Miner Res (2000) 0.87
Effect of interleukin 1 beta on osteoblastic clone MC3T3-E1 cells. Calcif Tissue Int (1988) 0.87
CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption. J Cell Biol (1999) 0.87
Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease. AJNR Am J Neuroradiol (2011) 0.87
Effects of recombinant human interleukin 1 alpha and interleukin 1 beta on cell growth and alkaline phosphatase of the mouse osteoblastic cell line MC3T3-E1. Biochim Biophys Acta (1988) 0.86
Human purified interleukin-1 inhibits DNA synthesis and cell growth of osteoblastic cell line (MC3T3-E1), but enhances alkaline phosphatase activity in the cells. FEBS Lett (1986) 0.86
Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes (2013) 0.86
Prostaglandin F2 alpha stimulates proliferation of clonal osteoblastic MC3T3-E1 cells by up-regulation of insulin-like growth factor I receptors. J Biol Chem (1991) 0.86
Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun (1996) 0.86
Effect of parenteral zinc sulfate on colon anastomosis repair in the rat. Int J Colorectal Dis (2008) 0.86
The unique action for bone metabolism of 1 alpha,25-(OH)2D3-26,23-lactone. Biochem Biophys Res Commun (1985) 0.85
Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative. Can J Vet Res (1991) 0.85
Electron microscopy of intranuclear inclusions in a mixed tumor. Oral Surg Oral Med Oral Pathol (1969) 0.85
Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol (2003) 0.85